UTHR Exercise Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Sep 11, 2026
Exercise
Calculated transaction value
$0
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Sep 10, 2026
Public filing date
Sep 11, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$503.86
Sep 10, 2026
Close before public filing
$503.86
Sep 10, 2026
Return since public filing
-1.34%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option on Common Stock
- Quantity / price
- 9,500 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001106578-26-000139
Filing cohort
Transactions in this filing
Showing 12 of 12
Trades
12
Issuers
1
Estimated value
$5.89M
Buys / sales
0 / 10
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Sep 10, 2026 | $141.89K |
| United Therapeutics Corp UTHR | Exercise | Sep 10, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Sep 10, 2026 | $59.81K |
| United Therapeutics Corp UTHR | Sale | Sep 10, 2026 | $893.55K |
| United Therapeutics Corp UTHR | Sale | Sep 10, 2026 | $686.8K |
| United Therapeutics Corp UTHR | Sale | Sep 10, 2026 | $1.13M |
| United Therapeutics Corp UTHR | Sale | Sep 10, 2026 | $772.3K |
| United Therapeutics Corp UTHR | Sale | Sep 10, 2026 | $291.17K |
| United Therapeutics Corp UTHR | Sale | Sep 10, 2026 | $354.53K |
| United Therapeutics Corp UTHR | Sale | Sep 10, 2026 | $303.56K |
| United Therapeutics Corp UTHR | Sale | Sep 10, 2026 | $142.47K |
| United Therapeutics Corp UTHR Current | Exercise | Sep 10, 2026 | $0 |